CDXC
$4.62
Chromadex Corp CS
$.20
4.52%
CDXC
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  ($0.11)
Revenue:  $18.97 Mil
Wednesday
Feb 2
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when CDXC reports earnings?
Beat
Meet
Miss

Where is CDXC's stock price going from here?
Up
Flat
Down
Stock chart of CDXC
Analysts
Summary of analysts' recommendations for CDXC
Score
Grade
Pivots
Resistance
$4.81
$4.66
$4.54

$4.38

Support
$4.26
$4.11
$3.99
Tweet
Growth
Description
ChromaDex Corporation and its subsidiaries supply phytochemical reference standards and reference materials, related contract services, and products for the dietary supplement, nutraceutical, food and beverage, functional food, pharmaceutical and cosmetic markets. ChromaDex's core business strategy is to use the intellectual property harnessed by its expertise in the area of natural products and in the creation of reference materials to the industry as the basis for providing new and alternative, green, mass marketable products to its customers. The Company's main priority is to create industry-accepted information, and to provide products and services to every layer of the functional food, pharmaceutical, personal care and dietary supplement markets. The company markets and sells its products in the United States and Canada. It offers its products through distributors in Europe, South America, Korea, India, Japan, Australia, New Zealand, China, Indonesia, Malaysia, Singapore, Thailand, and Mexico.